CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 2.36 HKD 2.61%
Market Cap: 3B HKD
Have any thoughts about
CStone Pharmaceuticals?
Write Note

CStone Pharmaceuticals
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CStone Pharmaceuticals
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
CStone Pharmaceuticals
HKEX:2616
Effect of Foreign Exchange Rates
-ÂĄ3.4m
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Effect of Foreign Exchange Rates
ÂĄ44.1m
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Effect of Foreign Exchange Rates
ÂĄ22.3m
CAGR 3-Years
N/A
CAGR 5-Years
0%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Effect of Foreign Exchange Rates
ÂĄ7.6m
CAGR 3-Years
N/A
CAGR 5-Years
50%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Effect of Foreign Exchange Rates
-ÂĄ2.1m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Effect of Foreign Exchange Rates
-ÂĄ833.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CStone Pharmaceuticals
Glance View

Market Cap
3B HKD
Industry
Biotechnology

Cstone Pharmaceuticals Co. Ltd. engages in the research and development of highly complex biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 264 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.

Intrinsic Value
2.93 HKD
Undervaluation 19%
Intrinsic Value
Price

See Also

What is CStone Pharmaceuticals's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-3.4m CNY

Based on the financial report for Jun 30, 2024, CStone Pharmaceuticals's Effect of Foreign Exchange Rates amounts to -3.4m CNY.

What is CStone Pharmaceuticals's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
76%

The average annual Effect of Foreign Exchange Rates growth rates for CStone Pharmaceuticals have been 76% over the past three years .

Back to Top